Docetaxel/paclitaxelDrug allergy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1776卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70327-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：169 / 169

相关论文

共 50 条

[1] Bevacizumab/carboplatin/paclitaxelDrug allergy manifesting as rash: case report
Reactions Weekly, 2017, 1658 (1) : 86 - 86
[2] PaclitaxelDrug eruption: case report
Reactions Weekly, 2015, 1542 (1) : 173 - 173
[3] PaclitaxelDrug eruption: case report
Reactions Weekly, 2013, 1469 (1) : 34 - 34
[4] Docetaxel/paclitaxelDrug induced lung damage: 2 case reports
Reactions Weekly, 2025, 2053 (1) : 131 - 131
[5] Carboplatin/paclitaxelDrug ineffective: case report
Reactions Weekly, 2023, 1984 (1) : 147 - 147
[6] Cisplatin/fluorouracil/paclitaxelDrug resistance: case report
Reactions Weekly, 2017, 1645 (1) : 91 - 91
[7] Bevacizumab/carboplatin/paclitaxelDrug ineffectiveness: case report
Reactions Weekly, 2022, 1932 (1) : 141 - 141
[8] Cisplatin/etoposide/paclitaxelDrug hypersensitivity: case report
Reactions Weekly, 2009, 1254 (1) : 16 - 17
[9] Nivolumab/PaclitaxelDrug intolerance and alck of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 757 - 757
[10] Carboplatin/nivolumab/paclitaxelDrug resistance and myalgia: case report
Reactions Weekly, 2023, 1940 (1) : 127 - 127

← 1 2 3 4 5 →